Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
KALA BIO
KALA
$17.1M
| $1.25M | ﹤0.01% |
135
+13
| +11% | +$126K |
|
3152
Loop Industries
LOOP
$32.2M
| $1.24M | ﹤0.01% |
125,590
+8,132
| +7% | +$87.5K |
|
3153
Takeda Pharmaceutical
TAK
$55.6B
| $1.24M | ﹤0.01% |
62,974
+16,710
| +36% | +$320K |
|
3154
Gencor Industries
GENC
$265M
| $1.24M | ﹤0.01% |
105,972
+497
| +0.5% | +$5.98K |
|
|
UROV
3155
DELISTED
Urovant Sciences Ltd.
UROV
| $1.24M | ﹤0.01% |
79,656
-4,306
| -5% | -$46.7K |
|
3156
Tecnoglass Holdings Inc.
TGLS
$1.86B
| $1.23M | ﹤0.01% |
149,385
| – | – |
|
3157
Veru
VERU
$46.7M
| $1.23M | ﹤0.01% |
36,598
+9,653
| +36% | +$215K |
|
3158
Solid Biosciences
SLDB
$971M
| $1.22M | ﹤0.01% |
18,348
+3,031
| +20% | +$334K |
|
3159
PrimeEnergy Resources
PNRG
$323M
| $1.22M | ﹤0.01% |
8,054
-171
| -2% | -$25.1K |
|
3160
Kodak
KODK
$992M
| $1.21M | ﹤0.01% |
260,723
| – | – |
|
|
ELVT
3161
DELISTED
Elevate Credit, Inc.
ELVT
| $1.21M | ﹤0.01% |
272,475
+27,977
| +11% | +$117K |
|
3162
Fulgent Genetics
FLGT
$515M
| $1.21M | ﹤0.01% |
93,793
+63,020
| +205% | +$749K |
|
|
RLH
3163
DELISTED
Red Lions Hotel Corporation
RLH
| $1.21M | ﹤0.01% |
323,089
+15,150
| +5% | +$70.7K |
|
3164
AstroNova
ALOT
$227M
| $1.2M | ﹤0.01% |
87,407
+1,136
| +1% | +$17.3K |
|
|
TIBRW
3165
DELISTED
Tiberius Acquisition Corporation Warrant
TIBRW
| $1.2M | ﹤0.01% |
1,050,001
+99,287
| +10% | +$113K |
|
3166
Personalis
PSNL
$1.52B
| $1.2M | ﹤0.01% |
109,737
+1,062
| +1% | +$11.1K |
|
|
STEX
3167
Streamex Corp
STEX
$87.3M
| $1.19M | ﹤0.01% |
20,185
+181
| +0.9% | +$12.2K |
|
3168
Ovid Therapeutics
OVID
$489M
| $1.19M | ﹤0.01% |
287,929
+60,887
| +27% | +$192K |
|
|
RNET
3169
DELISTED
RigNet, Inc.
RNET
| $1.18M | ﹤0.01% |
178,767
-8,801
| -5% | -$52.8K |
|
3170
AB InBev
BUD
$156B
| $1.17M | ﹤0.01% |
14,297
-1,696
| -11% | -$141K |
|
3171
Kornit Digital
KRNT
$817M
| $1.17M | ﹤0.01% |
34,205
+144
| +0.4% | +$4.77K |
|
|
CEO
3172
DELISTED
CNOOC Limited
CEO
| $1.17M | ﹤0.01% |
7,015
-134
| -2% | -$20.5K |
|
|
ARD
3173
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $1.17M | ﹤0.01% |
59,596
+5,269
| +10% | +$97K |
|
|
FREE
3174
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $1.16M | ﹤0.01% |
115,000
+15,000
| +15% | +$149K |
|
3175
Aspen Aerogels
ASPN
$510M
| $1.16M | ﹤0.01% |
149,414
-1,471
| -1% | -$10.2K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.